Insider buying last 90 days
No open-market insider purchases were filed for MD in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every MD insider filing, plotted on the chart in Gekko.Open MD in Gekko
NYSE: MD
Pediatrix Medical (MD) Stock Analysis & Forecast
Oct 12 close
$26.92+0.28 (+1.1%)
Gekko Brief
AI summaryOct 12 closePediatrix Medical draws attention this week mainly from recurring coverage of its growth profile and earnings trajectory rather than fresh news. One piece frames the stock as a long-term growth name, another relays an Argus forecast and rating dated 7 October, and a third revisits the Q2 2026 results, noting adjusted EPS of $0.63 versus $0.53 a year earlier, alongside soft patient volumes across hospital-based, office-based and neonatal intensive care unit services. Together these concern the tension between earnings growth and underlying volume trends rather than any new catalyst.
Shares closed at $26.92, up 1.1% on the day, sitting above both the 50-day average of $26.35 and the 200-day average of $23.42, with the 50-day above the 200-day. The GekkoIndex reads 53.7, placing MD in the Neutral zone, down 6.4 points over five sessions. Price stands 7.1% above Gekko Fair Value of $25.13.
Earnings are due 2 November, before the open, falling within the next 20 trading days and inside a typical holding window; the prior report on 4 August showed EPS of $0.63 against a $0.59 estimate, with a -1% reaction. Smart-money data shows no insider, Congress or unusual options activity in the respective 90-day and 30-day windows. Seasonality over five years shows a 10.2% average 20-day return from this calendar point, with gains in 3 of those years. Analyst consensus stands at 1 buy and 5 hold ratings, with a target of $26.33.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Pediatrix Medical price vs fair value
Close $26.92200-day averageGekko Fair Value $25.13
Pediatrix Medical quick facts
- Market cap
- $2.21B
- P/E ratio
- 12.6
- Forward P/E
- 9.3
- EPS, TTM
- $2.09
- Revenue, TTM
- $1.95B
- Profit margin
- 9%
- Dividend yield
- —
- Beta
- 0.61
- Volume
- 487,319 avg 755,646
- 1-year return
- +66.0%
- Typical daily move
- ±2.7%
- Typical 20-day move
- ±6.2%
- 50-day average
- $26.35
- 200-day average
- $23.42
- Next earnings
- Nov 2 before open
- Shares outstanding
- 81.25M
Pediatrix Medical swing-trade checklist
Pediatrix Medical scores 2 supportive, 1 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive1 mixed2 headwinds
- Trendsupportive
Above 50 and 200-day
Close $26.92 is above the 50-day ($26.35) and 200-day ($23.42) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexmixed
53.7, Neutral
Reading 53.7 is in the Neutral zone.
See the GekkoIndex - Fair valueheadwind
7.1% above
Price is 7.1% above Gekko Fair Value (more than 5% above).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings riskheadwind
Reports in 21 days
Reports on Nov 2, 2026, 21 days away — inside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+10.2% on average
From this point in the calendar, the next 20 trading days averaged +10.2% over 5 years, rising in 3 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Pediatrix Medical stock chart and price history
Pediatrix Medical closed at $26.92 on Oct 12, 2026, +66.0% over the past year, inside a 52-week range of $15.70 to $27.94.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +0.6%
- 3 months
- +11.7%
- 6 months
- +23.4%
- 1 year
- +66.0%
The full MD chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open MD in Gekko
Follow Pediatrix Medical through every session
Put MD on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track MD in GekkoFree for 7 days. No credit card required.
About Pediatrix Medical
Pediatrix Medical Group provides specialized clinical care to newborns, pregnant patients, and children in hospitals across the United States and Puerto Rico. Its work centers on neonatal care for critically ill or premature infants, handled by subspecialists and advanced practice clinicians working within hospital units. The group is particularly associated with this newborn-focused medical staffing model.
Alongside neonatal services, Pediatrix Medical offers maternal-fetal medicine for expectant mothers, drawing on physicians, obstetricians, and genetic counselors in both outpatient and inpatient settings. It also runs a pediatric cardiology practice treating congenital and acquired heart conditions from before birth into adulthood. Additional pediatric subspecialties, including intensive care, surgery, and ophthalmology, round out its offerings, and the group places staff within hospital emergency rooms and labor and delivery units, effectively functioning as a physician services provider to hospital systems.
Pediatrix Medical was founded in 1979 and is based in Sunrise, Florida; it operated under the name MEDNAX, Inc. before adopting its current name in July 2022. Its shares are listed on the NYSE under the ticker MD.
- Listed
- NYSE
- Sector
- Health services
- Industry
- Medical/Nursing services
- Website
- pediatrix.com
Pediatrix Medical GekkoIndex: the smart money zone
Pediatrix Medical’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 53.7, in the Neutral zone, down 6.4 points over five sessions.
53.7Neutral
Down 6.4 points over five sessions, from the Accumulation zone.
Reading for Oct 12, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 32 | +1.9% | +3.1% | ||
| Accumulation | 195 | +1.3% | +6.6% | ||
| Neutral (current zone) | 379 | +0.7% | +3.4% | ||
| Distribution | 73 | +0.8% | −0.1% | ||
| Selling | 3 | Too few readings yet | |||
Average MD share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the MD price, zone by zone.Track MD in Gekko
Is Pediatrix Medical stock overvalued? Gekko Fair Value
Pediatrix Medical trades 7.1% above Gekko Fair Value of $25.13, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what Pediatrix Medical shares are worth, recalculated every trading day.
$25.13
Gekko Fair Value, Oct 10, 2026
7.1% Overvalued
At the end of Aug 2026 the price was 1.5% above the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open MD in Gekko
Pediatrix Medical insider and Congress trading
No open-market insider purchases were filed for Pediatrix Medical, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in MD were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for MD, plotted on the chart in Gekko.Open MD in Gekko
Buybacks
Pediatrix Medical has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $42.74M
- As a share of market cap
- 1.93%
- Trailing four quarters
- $149.1M
From company filings.
Pediatrix Medical earnings: next date and track record
Pediatrix Medical reports on Nov 2, 2026, before the open (21 days away), and beat the EPS estimate in 7 of its last 8 reports.
Next earnings report
Nov 2, 2026
Expected before the open, 21 days away
- EPS estimate
- $0.65
- Revenue estimate
- $498.2M
7 of 8reports beat the EPS estimate
±13%average move across the report
5 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Aug 4, 2026 AI summary
- What they said
- Pediatrix Medical Group reported Q2 2026 adjusted EBITDA of $76 million, with consolidated revenue up 4% driven by acquisitions and 2% same-unit growth. Same-unit pricing rose 4% on strong RCM collections, favorable payer mix (+135 bps YoY), and higher acuity, though volumes fell 2% with NICU days down 3%. The company repurchased ~2M shares in Q2, totaling 7M shares since August 2025, with $289M cash and $584M debt. Strategic focus includes telehybrid medicine expansion and OBH growth.
- Guidance
- Management reaffirmed full year 2026 adjusted EBITDA guidance of $280M-$300M. Share buybacks will continue unless compelling acquisition opportunities emerge. The company is actively exploring JV and capital partnerships within women's and children's medicine.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 4, 2026 | $0.63 est $0.59 | $487.8M est $478.5M | −1.0% |
| May 5, 2026 | $0.44 est $0.37 | $476.2M est $465.8M | −0.9% |
| Feb 19, 2026 | $0.50 est $0.54 | $493.8M est $486.2M | −14.3% |
| Nov 3, 2025 | $0.67 est $0.46 | $492.9M est $486.2M | +26.3% |
| Aug 5, 2025 | $0.53 est $0.42 | $468.8M est $473.7M | +17.4% |
| May 6, 2025 | $0.33 est $0.25 | $458.4M est $459.7M | +10.8% |
| Feb 20, 2025 | $0.51 est $0.37 | $502.4M est $473.3M | +10.6% |
| Nov 1, 2024 | $0.44 est $0.37 | $511.2M est $487.1M | +22.9% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Pediatrix Medical stock forecast and analyst price targets
Analysts’ average 12-month price target for Pediatrix Medical is $26.33, −2.2% from the last close, from 6 firms rating the stock in the last 90 days.
$26.33consensus 12-month target, −2.2% from the last close
Now $26.92Avg $26.33
Low $25High $28
Each firm’s latest rating in the last 90 days: 6 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Aug 19 | Jefferies | $28 | +4.0% |
| Aug 11 | Mizuho Securities | $28 | +4.0% |
| Aug 6 | UBS | $28 | +4.0% |
| Aug 5 | Truist Financial | $28 | +4.0% |
| Aug 5 | Deutsche Bank | $25 | −7.1% |
+3.4%average 20-day move after past Neutral readings
+10.2%average move over the next 20 trading days in the last 5 years
±2.7%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Pediatrix Medical seasonality: the next 20 trading days
Over the next 20 trading days from Oct 10, Pediatrix Medical averaged +10.2% across the last 5 years, rising in 3 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +3.3% | 3 of 5 |
| Next 10 trading days | +4.9% | 4 of 5 |
| Next 15 trading days | +4.5% | 4 of 5 |
| Next 20 trading days | +10.2% | 3 of 5 |
| Next 30 trading days | +6.0% | 2 of 5 |
For scale, MD’s typical 20-trading-day move in either direction is about 6.2%.
Pediatrix Medical market cap and key statistics
Pediatrix Medical’s market cap is $2.21B, with a P/E ratio of 12.6 and revenue of $1.95B over the last twelve months.
Valuation
- Market cap
- $2.21B
- P/E ratio
- 12.6
- Forward P/E
- 9.3
- EPS, TTM
- $2.09
- Gekko Fair Value
- $25.13
Trading
- Volume
- 487,319
- Avg volume, 20 days
- 755,646
- 52-week high
- $27.94
- 52-week low
- $15.70
- Shares outstanding
- 81.25M
Financials
- Revenue, TTM
- $1.95B
- Profit margin
- 9%
- Return on equity
- 20.4%
- Quarterly earnings growth, YoY
- +6.5%
Risk and income
- Beta
- 0.61
- Typical daily move
- ±2.7%
- Typical 20-day move
- ±6.2%
Pediatrix Medical stock news this week
3 headlines about Pediatrix Medical from the past week, newest first, each linking to the publisher.
- Why Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-TermZacks Investment Research, Oct 9
- Pediatrix Medical Group, Inc. (MD) Stock ForecastsYahoo! Finance Canada, Oct 8
- Pediatrix Medical Group stock weighs earnings growth against soft volumesAD HOC NEWS, Oct 6
Pediatrix Medical peers
Pediatrix Medical’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| LHLabcorp | Neutral | 2.5% below |
| GHGuardant Health | Accumulation | 10.0% below |
| SOLVSolventum | Accumulation | 20.5% below |
| BTSGBrightSpring Health Services | Neutral | 2.8% above |
| EHCEncompass Health | Neutral | 7.3% above |
| DVADaVita | Neutral | 14.6% below |
A peer links to its own page where one exists.
Pediatrix Medical stock FAQ
What is Pediatrix Medical’s market cap?
Pediatrix Medical’s market cap is $2.21B at the Oct 12, 2026 close of $26.92, with 81.25M shares outstanding. The shares trade on a P/E ratio of 12.6.
What is the Pediatrix Medical stock forecast?
The consensus analyst 12-month price target for Pediatrix Medical is $26.33, −2.2% from the last close. Of the 6 firms that rated the stock in the last 90 days, 1 rate it a buy, 5 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Pediatrix Medical stock overvalued or undervalued?
On Gekko’s estimate Pediatrix Medical is overvalued: the Oct 12, 2026 close of $26.92 is 7.1% above Gekko Fair Value of $25.13. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Pediatrix Medical report earnings next?
Pediatrix Medical is expected to report on Nov 2, 2026, before the market opens (21 days away). Analysts expect earnings of $0.65 per share on revenue of $498.2M. Pediatrix Medical beat the earnings estimate in 7 of its last 8 reports, moving 13% on average across the report.
What is Pediatrix Medical’s 52-week high and low?
Pediatrix Medical’s 52-week high is $27.94 and its 52-week low is $15.70; it closed at $26.92 on Oct 12, 2026, +66.0% over the past year. Over the last five years the shares peaked at $29.07 on Oct 28, 2021.
Is Pediatrix Medical stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (trend and seasonality), 1 as mixed (gekkoindex) and 2 as headwinds (fair value and earnings risk). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Pediatrix Medical the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.